SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lamba Sanjiv
(Last) (First) (Middle)
C/O LINDE PLC
FORGE, 43 CHURCH STREET WEST
(Street)
WOKING SURREY X0 GU216HT
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 03/10/2025 M 6,335(1) A $0 74,610.95 D
Ordinary Shares 03/10/2025 F 2,786.767(2) D $468.77 71,824.183 D
Ordinary Shares 03/10/2025 M 19,000(3) A $0 90,824.183 D
Ordinary Shares 03/10/2025 F 8,804.601(2) D $468.77 82,019.582 D
Ordinary Shares 03/10/2025 M 11,656(3) A $0 93,675.582 D
Ordinary Shares 03/10/2025 F 5,401.391(2) D $468.77 88,274.191 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Share Units (ROC) $0 03/10/2025 A 19,000 (4) (4) Ordinary Shares 19,000 $0 19,000 D
Performance Share Units (ROC) $0 03/10/2025 M 19,000 (4) (4) Ordinary Shares 19,000 $0 0 D
Performance Share Units (RTSR) $0 03/10/2025 A 11,656 (5) (5) Ordinary Shares 11,656 $0 11,656 D
Performance Share Units (RTSR) $0 03/10/2025 M 11,656 (5) (5) Ordinary Shares 11,656 $0 0 D
Restricted Stock Units (6) 03/10/2025 M 6,335 (7) (7) Ordinary Shares 6,335 $0 0 D
Restricted Stock Units $0 03/07/2025 A 6,364 (8) (8) Ordinary Shares 6,364 $0 6,364 D
Restricted Stock Units (9) (9) (9) Ordinary Shares 6,405 6,405 D
Restricted Stock Units (10) (10) (10) Ordinary Shares 7,015 7,015 D
Stock Options (right to buy) $468.77 03/07/2025 A 44,696 (11) 03/07/2035 Ordinary Shares 44,696 $0 44,696 D
Stock Options (right to buy) $465.29 (12) 03/07/2034 Ordinary Shares 41,530 41,530 D
Stock Options (right to buy) $354.14 (13) 03/07/2033 Ordinary Shares 46,365 46,365 D
Stock Options (right to buy) $270.99 (14) 03/07/2032 Ordinary Shares 54,920 54,920 D
Stock Options (right to buy) $253.68 (15) 03/08/2031 Ordinary Shares 40,995 40,995 D
Stock Options (right to buy) $173.13 (16) 03/09/2030 Ordinary Shares 37,565 37,565 D
Stock Options (right to buy) $176.63 (17) 03/20/2029 Ordinary Shares 15,470 15,470 D
Deferred Stock Units $0(6) (18) (18) Ordinary Shares 406.322 406.322 D
Explanation of Responses:
1. Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022.
2. Ordinary shares withheld from the payout to cover tax withholdings.
3. Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022.
4. The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
5. The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
6. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
7. Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis
8. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
9. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
10. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
11. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
12. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
13. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
14. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
15. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
16. Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
17. This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.
18. Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.
Remarks:
Anthony M. Pepper as attorney-in-fact 03/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Linde (NASDAQ:LIN)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Linde Charts.
Linde (NASDAQ:LIN)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Linde Charts.